- Home
- Applications
- asia middle east
- clinical outcomes
Show results for
Refine by
Clinical Outcomes Product Applications In Asia Middle East
3 applications found
Shifting from Crisis Management to Health Maintenance. With an unparalleled approach, Vectorious’ V-LAP platform is emerging as the treatment choice for heart failure ...
ByVectorious based in Tel Aviv, ISRAEL
Gene expression is the most fundamental level at which the genotype gives rise to a phenotype. Whether you have RNA-Seq, qPCR or microarray data, Partek provides easy-to-use tools that guide you through the analysis process from start to finish within a point-and-click interface. With over 8,000 citations, see why our gene expression analysis tools are the most trusted in the genomics ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA